- Pacira BioSciences (PCRX) signed an exclusive agreement with Molteni Farmaceutici to distribute and commercialize EXPAREL in the European Union and U.K.
- Under the agreement, Pacira will receive an undisclosed upfront payment, a supply price, and royalties on future commercial sales in the licensed
Pacira taps Molteni to expand EXPAREL sales across EU and U.K (PCRX:NASDAQ)
